Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

STSS

Sharps Technology Inc

Apr 18 • 04:00PM ET

0.3100

Dollar change -0.0048
Percentage change -1.52	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.79	Insider Own	8.72%	Shs Outstand	15.27M	Perf Week	-13.41%
Market Cap	4.86M	Forward P/E	-	EPS next Y	-	Insider Trans	7.40%	Shs Float	14.30M	Perf Month	2.31%
Income	-9.84M	PEG	-	EPS next Q	-	Inst Own	16.73%	Short Float	1.61%	Perf Quarter	-4.02%
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	-2.23%	Short Ratio	1.23	Perf Half Y	-33.90%
Book/sh	0.52	P/B	0.60	EPS next Y	-	ROA	-83.30%	Short Interest	0.23M	Perf Year	-73.73%
Cash/sh	0.19	P/C	1.61	EPS next 5Y	-	ROE	-111.99%	52W Range	0.27 - 1.58	Perf YTD	-25.46%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-35.49%	ROI	-124.04%	52W High	-80.38%	Beta	1.02
Dividend TTM	-	Quick Ratio	0.85	Sales past 5Y	0.00%	Gross Margin	-	52W Low	14.77%	ATR (14)	0.04
Dividend Ex-Date	-	Current Ratio	1.31	EPS Y/Y TTM	-58.07%	Oper. Margin	0.00%	RSI (14)	43.59	Volatility	14.18% 12.42%
Employees	57	Debt/Eq	0.00	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	16.00
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	-124.92%	Payout	-	Rel Volume	0.39	Prev Close	0.31
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	-	Avg Volume	186.75K	Price	0.31
SMA20	-5.70%	SMA50	-6.46%	SMA200	-40.26%	Trades		Volume	73,176	Change	-1.52%

Apr-01-24 10:52AM	STSS Stock Earnings: Sharps Technology Reported Results for Q4 2023 (InvestorPlace)
Mar-07-24 08:00AM	Sharps Technology and Roncadelle Operations Sign Worldwide Sales and Distribution Agreement for their Innovative Portfolio of Safe Technology Drug Delivery Systems (GlobeNewswire) -7.54%
Feb-21-24 08:00AM	Sharps Technology Enters Latin American Market and Receives First Orders for Securegard Disposable Smart Safety Syringes from Strategic Distribution Partner in Colombia (GlobeNewswire) +15.33%
Feb-16-24 02:42PM	Sharps Technology Planning To Collaborate With Roncadelle To Support Global Distribution And Sales Of High Quality, Innovative, Safer Drug Delivery Systems (GlobeNewswire) +8.38%
Jan-18-24 09:00AM	Sharps Technology Signs LOI with Roncadelle Operations Intended to Open Worldwide Sales and Distribution Opportunities for Safe Drug Delivery Systems (GlobeNewswire)
10:30AM	Loading…
Sep-29-23 10:30AM	Aegis Capital Corp. Acted as Exclusive Placement Agent on a $5.6 Million Registered Direct & Private Placement Priced at the Market Under Nasdaq Rules for Sharps Technology, Inc. (NASDAQ: STSS) (ACCESSWIRE) -6.45%
09:54AM	Sharps Technology Announces Closing of $5.6 Million Registered Direct and Private Placement (GlobeNewswire)
09:00AM	Sharps Technology, Reviva Pharmaceuticals, and American Resources Corp. Interviews to Air on the RedChip Money Report(R) on Bloomberg TV (ACCESSWIRE)
Sep-28-23 10:52AM	Sharps Technology Issues Letter to Shareholders Covering the Announced Asset Purchase Agreement to Acquire InjectEZ Prefillable Syringe Manufacturing Facility and the Associated $400 Million 10-Year Purchase Agreement with Nephron Pharmaceuticals (GlobeNewswire)
Sep-27-23 12:03PM	UPDATE - Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules (GlobeNewswire) -30.40%
09:14AM	Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules (GlobeNewswire)
Sep-26-23 08:30AM	Sharps Technology Signs Asset Purchase Agreement to Acquire InjectEZ Specialty Copolymer Syringe Manufacturing Facility and a 10-Year Purchase Agreement for Over $400 Million from Nephron Pharmaceuticals (GlobeNewswire) +26.19%
Sep-22-23 07:31AM	Sharps Technology, Inc. CEO is Featured in an Interview with SmallCapsDaily (NewMediaWire)
Aug-02-23 12:45PM	RedChip Launches 'Small Stocks, Big Money' Podcast (ACCESSWIRE)
Jul-12-23 08:33AM	Sharps Technology Appoints Industry Sales and Manufacturing Leader Ben Scheu as Senior Director of Sales (GlobeNewswire)
07:50AM	Loading…
Jul-06-23 07:50AM	Sharps Technology Provides Update on Commercialization Activities and is Highlighted in Med Tech Outlook Feature Article (GlobeNewswire) +8.97%
May-19-23 09:00AM	Sharps Technology, Inc. and BullFrog AI Holdings, Inc. Interviews to Air on Bloomberg TV on the RedChip Money Report(R) (ACCESSWIRE)
May-06-23 10:18AM	We Might See A Profit From Sharps Technology, Inc. (NASDAQ:STSS) Soon (Simply Wall St.)
Apr-05-23 07:05AM	BullFrog AI and Sharps Technology Interviews to Air on Bloomberg U.S. on the RedChip Money Report(R) (ACCESSWIRE)
Apr-04-23 08:00AM	Sharps Technology Issues Update Letter to Shareholders from CEO Robert Hayes (GlobeNewswire)
Mar-01-23 09:40AM	Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company? (News Direct)
Feb-15-23 09:55AM	With COVID-19 Having Placed A Sharp Focus On Syringes, This Innovator Looks Back At A Year Of Successes Since Their 2022 IPO (News Direct)
Feb-09-23 09:21AM	Sharps Technology Appoints Justin Page as Vice President of Technical Operations (GlobeNewswire)
Feb-06-23 09:50AM	Aegis Capital Corp. Acted as Exclusive Placement Agent on a $3.8 Million Private Placement for Sharps Technology, Inc. (NASDAQ:STSS) (ACCESSWIRE)
09:02AM	Sharps Technology Announces Closing of $3.8 Million Private Placement Priced At-the-Market (GlobeNewswire)
Feb-01-23 09:20AM	Sharps Technology Announces Pricing of $3.8 Million Private Placement Priced at the Market (GlobeNewswire) -13.16%
Jan-31-23 08:00AM	Sharps Technology Ships First Containers of Safety Syringes to Nephron Pharmaceuticals for Commercialization (GlobeNewswire) +6.15%
Jan-30-23 06:00AM	STSS: Drug delivery medical device company with a strong line of specialty safety syringe products signs strategic partnership with Nephron Pharmaceuticals that positions the company for strong revenue growth in 2023. (Zacks Small Cap Research) +31.62%
Jan-17-23 10:00AM	Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products (News Direct) -7.36%
Jan-12-23 12:51PM	Global Drug Delivery Systems Market Size Projected to Reach $71.75 Billion By 2029 (News Direct)
09:25AM	Loading…
09:25AM	Sharps Technology Is Injecting A Better Solution Into The Healthcare Syringe Industry (News Direct)
Jan-10-23 08:00AM	Sharps Technology Inc. to Introduce New Specialized Prefillable Syringe Systems in 2023 (GlobeNewswire) -11.98%
Jan-04-23 08:13AM	Great news for Sharps Technology, Inc. (NASDAQ:STSS): Insiders acquired stock in large numbers last year (Simply Wall St.) +9.21%
Dec-20-22 08:00AM	Sharps Technology Begins Manufacturing at its Hungary Facility for the Company's Innovative Syringe Products (GlobeNewswire)
Dec-13-22 08:00AM	Sharps Technology and Nephron Pharmaceuticals Sign Distribution Agreement for its Innovative Syringe Products (GlobeNewswire) -9.60%
Nov-24-22 06:08AM	Breakeven Is Near for Sharps Technology, Inc. (NASDAQ:STSS) (Simply Wall St.)
Nov-10-22 04:05PM	Nephron Pharmaceuticals Corporation and Sharps Technology, Inc. Announce Manufacturing and Research Partnership (GlobeNewswire)
Jul-15-22 07:33AM	Multiple insiders bought Sharps Technology, Inc. (NASDAQ:STSS) stock earlier this year, a positive sign for shareholders (Simply Wall St.) -5.56%
Jul-14-22 04:05PM	Sharps Technology Completes Acquisition of Safegard Medical Syringe Manufacturing Facility (GlobeNewswire)
Jun-08-22 04:05PM	Sharps Technology Announces Letter to Shareholders (GlobeNewswire)
May-06-22 03:15PM	Follow the Insiders and Buy the Dip in These 3 Stocks (InvestorPlace) -5.11%
Apr-19-22 10:20AM	Aegis Capital Corp. Acted as Sole Bookrunner on a ~$16 Million Initial Public Offering for Sharps Technology, Inc. (NASDAQ: STSS) (ACCESSWIRE) +40.46%
09:50AM	Sharps Technology, Inc. Announces Closing of $16 Million Initial Public Offering (GlobeNewswire)
Apr-13-22 09:34PM	Sharps Technology Announces Pricing of Initial Public Offering (GlobeNewswire)

Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. It also focuses on low waste, and ultra-low waste syringe technologies that incorporate both passive and active safety features. The company was founded by Alan R. Blackman and Barry B. Berler on December 16, 2017 and is headquartered in Melville, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hayes Robert Michael	Chief Executive Officer	Feb 20 '24	Buy	0.34	10,000	3,400	95,882	Feb 21 09:33 PM
Hayes Robert Michael	Chief Executive Officer	Feb 06 '24	Buy	0.29	10,000	2,900	85,882	Feb 07 02:05 PM
Hayes Robert Michael	Chief Executive Officer	Feb 02 '24	Buy	0.35	8,000	2,800	75,882	Feb 05 08:45 PM
Hayes Robert Michael	Chief Executive Officer	Jan 31 '24	Buy	0.38	2,200	846	67,882	Feb 05 08:45 PM
Ruemler Timothy James	Director	Jan 03 '24	Buy	0.40	5,000	2,000	1,061,675	Jan 04 08:27 AM
Ruemler Timothy James	Director	Jan 02 '24	Buy	0.40	4,466	1,786	1,056,675	Jan 04 08:27 AM
Crescenzo Andrew R.	Chief Financial Officer	Dec 28 '23	Buy	0.42	3,500	1,476	15,500	Dec 29 03:02 PM
Ruemler Timothy James	Director	Dec 22 '23	Buy	0.40	10,000	4,016	1,052,209	Dec 22 05:45 PM
Ruemler Timothy James	Director	Nov 22 '23	Buy	0.45	10,000	4,500	1,032,209	Nov 24 08:30 AM
Ruemler Timothy James	Director	Nov 22 '23	Buy	0.45	10,000	4,500	1,042,209	Nov 27 08:12 AM
Ruemler Timothy James	Director	Nov 20 '23	Buy	0.41	5,000	2,074	1,022,209	Nov 21 05:23 PM
Ruemler Timothy James	Director	Nov 17 '23	Buy	0.41	10,000	4,100	1,021,209	Nov 21 05:23 PM
Ruemler Timothy James	Director	Nov 16 '23	Buy	0.40	3,500	1,402	1,017,209	Nov 17 05:24 PM
Ruemler Timothy James	Director	Nov 15 '23	Buy	0.41	2,500	1,025	1,013,709	Nov 17 05:24 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

STSS

Sharps Technology Inc

Upgrade your FINVIZ experience